Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goran B G Klintmalm

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 4, 2006
A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic studyW Kenneth Washburn, Lewis W Teperman, Thomas G Heffron, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2007
Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 studyGoran B G Klintmalm, W Kenneth Washburn, Steven M Rudich, et al.
Transplantation|September 28, 2004
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters, Kristin N Spinola, John C West, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 4, 2006
A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic studyW Kenneth Washburn, Lewis W Teperman, Thomas G Heffron, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2007
Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 studyGoran B G Klintmalm, W Kenneth Washburn, Steven M Rudich, et al.
Transplantation|September 28, 2004
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effectsThomas G Peters, Kristin N Spinola, John C West, et al.
Pageof 1